Organon & Co | OGN - Debt


Organon & Co reported $8.83B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Celltrion KRW 171.09B 2.05T Jun/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Gilead Sciences USD 24.94B 5M Sep/2025
Glaxosmithkline GBP 17.75B 396M Sep/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Merck USD 41.37B 5.97B Sep/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Novartis USD 32.02B 615M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 51.4M 405K Jun/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tilray USD 640.95M 35.17M Jun/2022